Lack of prophylactic efficacy of an enteric-coated bovine hyperimmune milk product against enterotoxigenic Escherichia coli challenge administered during a standard meal.
Quick navigation
Link to full study
http://www.ncbi.nlm.nih.gov/pubmed/10558970
Conclusion of this study
There was no difference in the incidence or severity of diarrhea among the 10 volunteers who received the bovine immunoglobulins and the 10 who received placebo. Either the specificity or titer of anti-colonization factor antibodies or the formulation of antibodies in this product was not adequate to provide passive protection against ETEC challenge.
Supplements analyzed in this study
Health conditions analyzed in this study
Functions related to this study
Body systems related to this study